Table 1.
A | O | C | Asia1 | SAT1 | SAT2 | SAT3 | A | O | C | Asia1 | SAT1 | SAT2 | SAT3 | |||
129 | 47 | 49 | 8 | 9 | 10 | 3 | 3 | 83 | 6 | 31 | 16 | 26 | 1 | 2 | 1 | |
A | 47 | 47 | 6 | 6 | ||||||||||||
O | 48 | 48 | 31 | 31 | ||||||||||||
C | 8 | 8 | 16 | 16 | ||||||||||||
Asia1 | 9 | 9 | 26 | 26 | ||||||||||||
SAT1 | 9 | 9 | 1 | 1 | ||||||||||||
SAT2 | 4 | 1 | 3 | 2 | 2 | |||||||||||
SAT3 | 4 | 1 | 3 | 1 | 1 |
The composition of the different serotype FMDV strains in our two datasets (columns 2 and 10). The LOOCV genotype prediction results on the first dataset are in row 2 from columns 3 to 9 and more details in rows 3–9 and columns 3–9 as a confusion matrix; the independent testing results on the second dataset are in row 2 from columns 11–17 and more details in rows 3–9 and columns 11–17 as a confusion matrix. Numbers in bold denote the correct genotype predictions.